Simponi 50 mg solution for injection in pre-filled syringe
Last Updated on eMC 21-Feb-2017 View document | Merck Sharp & Dohme Limited Contact details
Versions
- 21-Feb-2017 to Current
- 08-Jul-2016 to 21-Feb-2017
- 04-Jan-2016 to 08-Jul-2016
- 08-Jul-2015 to 04-Jan-2016
- 23-Jan-2015 to 08-Jul-2015
- 23-Oct-2014 to 23-Jan-2015
- 29-Jul-2014 to 23-Oct-2014
- 07-Jul-2014 to 29-Jul-2014
- 23-Oct-2013 to 07-Jul-2014
- 05-Sep-2013 to 23-Oct-2013
- 02-Aug-2013 to 05-Sep-2013
- 30-Apr-2013 to 02-Aug-2013
- 20-Dec-2012 to 30-Apr-2013
- 26-Sep-2012 to 20-Dec-2012
- 23-Feb-2012 to 26-Sep-2012
- 22-Sep-2011 to 23-Feb-2012
- 16-Jun-2011 to 22-Sep-2011
- 10-May-2011 to 16-Jun-2011
- 11-Mar-2011 to 10-May-2011
- 18-Feb-2011 to 11-Mar-2011
- 28-Sep-2010 to 18-Feb-2011
When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.
Updated on 21-Feb-2017 and displayed until Current
Reasons for adding or updating:
- Change to section 4 - possible side effects
- Change to section 6 - date of revision
Updated on 08-Jul-2016 and displayed until 21-Feb-2017
Reasons for adding or updating:
- Change to section 1 - what the product is used for
- Change to section 2 - what you need to know - warnings and precautions
- Change to section 2 - use in children/adolescents
- Change to section 2 - interactions with other medicines, food or drink
- Change to section 3 - dose and frequency
- Change to section 6 - date of revision
Updated on 04-Jan-2016 and displayed until 08-Jul-2016
Reasons for adding or updating:
- Change to section 2 - what you need to know - warnings and precautions
- Change to section 2 - interactions with other medicines, food or drink
- Change to section 4 - possible side effects
- Change to section 6 - date of revision
Updated on 08-Jul-2015 and displayed until 04-Jan-2016
Reasons for adding or updating:
- Change to section 1 - what the product is used for
- Change to section 3 - dose and frequency
- Change to section 6 - date of revision
Updated on 23-Jan-2015 and displayed until 08-Jul-2015
Reasons for adding or updating:
- Change to section 6 - date of revision
- Correction of spelling/typing errors
Updated on 23-Oct-2014 and displayed until 23-Jan-2015
Reasons for adding or updating:
- Change to section 4 - possible side effects
- Change to section 6 - date of revision
Updated on 29-Jul-2014 and displayed until 23-Oct-2014
Reasons for adding or updating:
- Change to section 4 - possible side effects
- Change to section 6 - date of revision
Updated on 07-Jul-2014 and displayed until 29-Jul-2014
Reasons for adding or updating:
- Change to section 2 - what you need to know - warnings and precautions
- Change to section 2 - interactions with other medicines, food or drink
- Change to section 2 - pregnancy, breast feeding and fertility
- Change to section 3 - overdose, missed or forgotten doses
- Change to section 6 - date of revision
Updated on 23-Oct-2013 and displayed until 07-Jul-2014
Reasons for adding or updating:
- Change to section 6 - date of revision
- Change to section 1 - what the product is used for
- Change to section 2 - what you need to know - warnings and precautions
- Change to section 3 - dose and frequency
- Change to section 4 - possible side effects
Updated on 05-Sep-2013 and displayed until 23-Oct-2013
Reasons for adding or updating:
- Change to section 4 - possible side effects
- Change to section 4 - how to report a side effect
- Change to section 6 - date of revision
Updated on 02-Aug-2013 and displayed until 05-Sep-2013
Reasons for adding or updating:
- Change to section 2 - what you need to know - warnings and precautions
- Change to section 6 - date of revision
Updated on 30-Apr-2013 and displayed until 02-Aug-2013
Reasons for adding or updating:
- Change to section 2 - what you need to know - warnings and precautions
- Change to section 6 - date of revision
- Improved presentation of PIL
Updated on 20-Dec-2012 and displayed until 30-Apr-2013
Reasons for adding or updating:
- Change to section 2 - what you need to know - warnings and precautions
- Change to section 2 - interactions with other medicines, food or drink
- Change to section 4 - possible side effects
- Change to section 6 - date of revision
Updated on 26-Sep-2012 and displayed until 20-Dec-2012
Reasons for adding or updating:
- Change to date of revision
- Change to side-effects
- Removal of Black Triangle
Updated on 23-Feb-2012 and displayed until 26-Sep-2012
Reasons for adding or updating:
- Change to date of revision
- Change to side-effects
Updated on 22-Sep-2011 and displayed until 23-Feb-2012
Reasons for adding or updating:
- Change to date of revision
- Change to warnings or special precautions for use
- Extra statutory information
Updated on 16-Jun-2011 and displayed until 22-Sep-2011
Reasons for adding or updating:
- Change to date of revision
- Change to, or new, use for medicine
- Change to side-effects
Updated on 10-May-2011 and displayed until 16-Jun-2011
Reasons for adding or updating:
- Change to date of revision
- Change to warnings or special precautions for use
- Change to information about pregnancy or lactation
Updated on 11-Mar-2011 and displayed until 10-May-2011
Reasons for adding or updating:
- Change to date of revision
- Change to side-effects
Updated on 18-Feb-2011 and displayed until 11-Mar-2011
Reasons for adding or updating:
- Change to date of revision
- Change to warnings or special precautions for use
- Change to dosage and administration
- Extra statutory information
Updated on 28-Sep-2010 and displayed until 18-Feb-2011
Reasons for adding or updating:
- New PIL for new product
Merck Sharp & Dohme Limited
Hertford Road, Hoddesdon, Hertfordshire, EN11 9BU
+44 (0)1992 479 292
Call MSD customer services on 01992 452094
Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Active ingredients
Legal categories
This site uses cookies. By continuing to browse the site you are agreeing to our policy on the use of cookies. Continue